Ansari M

Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.

7 papers

ArticleKetamine

Feasibility and tolerability of virtual reality during esketamine treatment: A pilot study.

Curran E, Kumpf KT, Ansari M +4

Europe PMC2026
ArticlePsilocybin

Placebo Effects in the Treatment of Depression-Implications for the Psychedelic Renaissance.

Ansari M, Elliott SI, Holmes SE +1

Europe PMC2026
ArticleKetamine

Ketamine Versus Electroconvulsive Therapy for the Treatment of Depression: A Guide for Clinicians.

Elliott SI, B Katz R, B Ostroff R +3

Europe PMC2025
ArticleKetamine

Does BMI matter when treating depression with esketamine? A retrospective analysis of real-world data.

Ansari M, Rhee TG, Santucci MC +1

Europe PMC2025
ArticleKetamine

Efficacy and Safety of Ketamine/Esketamine in Bipolar Depression in a Clinical Setting.

Santucci MC, Ansari M, Nikayin S +3

Europe PMC2024
ArticleKetamine

The Role of Awe and Other Psychological Factors in Ketamine's Mechanism of Antidepressant Action.

Ansari M, Sanacora G

Europe PMC2024
ArticleKetamine

Blood pressure changes during ketamine infusion for the treatment of depression.

Ansari M, Pittman B, Tylee DS +3

Europe PMC2024